The present study deals with the outer membrane OprD porin protein in 29 clinical bacterial isolates of multidrug-resistant Pseudomonas aeruginosa. oprD porin gene expression was investigated using real-time reverse transcription-PCR. Amplicons from oprD and its transcriptional regulator mexT gene were sequenced and analyzed for mutations. Hypothetical models of selected mutant OprD-porin proteins were predicted and refined by homology modeling approach. oprD ampliconic sequences were also screened for restriction fragment length polymorphism (RFLP). The oprD gene was found to be downregulated in 89.7% (n = 26) of the isolates in comparison to the transcript levels in the reference strain P. aeruginosa—PAO (MTCC-3541). Interestingly, all these isolates displayed the presence of a conspicuous 8-bp deletion (GGCCAGCC) at nucleotide position 235 of mexT regulatory gene. Based on the mutational patterns observed in oprD gene, the isolates were classified into categories designated as A, B1-2, C1-4, D1-6, E1-2, and F. Our hypothetical models revealed that mutations were predominantly confined to the extracellular loops emanating from the β-barrel porin protein. These protein models also enabled clear visualization of loss of substantial portions of the truncated polypeptide. Incidentally, since most of the oprD amplicons of the clinical isolates were found to display distinct RFLP banding patterns, our results also provide a useful diagnostic tool for detection of P. aeruginosa porin mutants.
Get full access to this article
View all access options for this article.
References
1.
BreidensteinE.B., de la Fuente-NúñezC., and HancockR.E.. 2011. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19:419–426.
Sanz-GarcíaF., Hernando-AmadoS., and MartínezJ.L.. 2018. Mutational evolution of Pseudomonas aeruginosa resistance to ribosome-targeting antibiotics. Front. Genet. 9:451.
4.
MoubareckC.A., HalatD.H, AkkawiC., NabiA., AlSharhanM.A, AlDeesiZ.O, PetersC.C, CelilogluH., and SarkisD.K.. 2019. Role of outer membrane permeability, efflux mechanism, and carbapenemases in carbapenem-nonsusceptible Pseudomonas aeruginosa from Dubai hospitals: results of the first cross-sectional survey. Int. J. Infect. Dis. 84:143–150.
5.
AsempaT.E., NicolauD.P, and KutiJ.L.. 2019. Carbapenem-nonsusceptible Pseudomonas aeruginosa isolates from intensive care units in the United States: a potential role for new β-lactam combination agents. J. Clin. Microbiol. 57:e00535-19.
6.
ZengZ.R., WangW.P, HuangM., ShiL.N, WangY., and ShaoH.F.. 2014. Mechanisms of carbapenem resistance in cephalosporin- susceptible Pseudomonas aeruginosa in China. Diagn. Microbiol. Infect. Dis. 78:268–270.
7.
KimC.H., KangH.Y, KimB.R, JeonH., LeeY.C, LeeS.H, and LeeJ.C.. 2016. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals. J. Microbiol. 54:44–49.
8.
FernándezL., and HancockR.E.W. 2012. Adaptive and mutational resistance: role of porins and efflux pumps in drug resistance. Clin. Microbiol. Rev. 25:661–681.
9.
GaldieroS., FalangaA., CantisaniM., TaralloR., PepaM.E.D, D'OrianoV., and GaldieroM.. 2012. Microbe-host interactions: structure and role of gram-negative bacterial porins. Curr. Protein Pept. Sci. 13:843–854.
10.
LiH., LuoY.-F, WilliamsB.J, BlackwellT.S, and XieC.-M.. 2012. Structure and function of OprD protein in Pseudomonas aeruginosa: from antibiotic resistance to novel therapies. Int. J. Med. Microbiol. 302:63–68.
11.
PirnayJ.P., De VosD., MossialosD., VanderkelenA., CornelisP., and ZiziM.. 2002. Analysis of the Pseudomonas aeruginosa oprD gene from clinical and environmental isolates. Environ. Microbiol. 4:872–882.
12.
ListerP.D., WolterD.J, and HansonN.D.. 2009. Antibacterial- resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin. Microbiol. Rev. 22:582–610.
13.
BiswasS., MohammadM.M, PatelD.R, MovileanuL., and van den BergB.. 2007. Structural insight into OprD substrate specificity. Nat. Struct. Mol. Biol. 14:1108–1109.
14.
OchsM.M., LuC.D, HancockR.E.W, and AbdelalA.T.. 1999. Amino acid-mediated induction of the basic amino acid-specific outer membrane porin OprD from Pseudomonas aeruginosa. J. Bacteriol. 181:5426–5432.
15.
Clinical and Laboratory Standards Institutes (CLSI) (2012) Performance standards for antimicrobial susceptibility testing: 22nd informational supplement, M100-S22. Wayne, PA: CLSI.
16.
SureshM., NithyaN., JayasreeP.R, VimalK.P, and Manish KumarP.R.. 2018. Mutational analyses of regulatory genes, mexR, nalC, nalD and mexZ of mexAB-oprM and mexXY operons, in efflux pump hyperexpressing multidrug-resistant clinical isolates of Pseudomonas aeruginosa. World J. Microbiol. Biotechnol. 34:83.
17.
SavliH., KaradenizliA., KolayliF., GundesS., OzbekU., and VahabogluH.. 2003. Expression stability of six housekeeping genes: a proposal for resistance gene quantification studies of Pseudomonas aeruginosa by real-time quantitative RT-PCR. J. Med. Microbiol. 52:403–408.
18.
DumasJ.L., van DeldenC., PerronK., and KöhlerT.. 2006. Analysis of antibiotic resistance gene expression in Pseudomonas aeruginosa by quantitative real-time-PCR. FEMS Microbiol. Lett. 254:217–225.
19.
Pfaffl, M.W. 2001. A new mathematical model for relative quantification in real-time RT–PCR. Nucleic Acids Res. 29:e45.
20.
AusubelF.M., BrentR., KingstonR.E, MooreD.D, SeidmanJ.G, SmithJ.A, and StruhlK.. 1995. Short Protocols in Molecular Biology. 3rd ed. Hoboken, NJ: John Wiley & Sons, Inc., pp. 2.11–2.12.
21.
WolterD.J., HansonN.D, and ListerP.D.. 2004. Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance. FEMS Microbiol. Lett. 236:137–143.
22.
QualeJ., BratuS., GuptaJ., and LandmanD.. 2006. Interplay of efflux system, ampC, and oprD expression in carbapenem resistance of Pseudomonas aeruginosa clinical Isolates. Antimicrob. Agents Chemother. 50:1633–1641.
23.
WebbB., and SaliA.. 2016. Comparative protein structure modeling using modeller. Curr. Protoc. Bioinformatics. 54:5.6.1–5.6.37.
24.
XuD., and ZhangY.. 2011. Improving the physical realism and structural accuracy of protein models by a two-step atomic-level energy minimization. Biophys. J. 101:2525–2534.
25.
MaitiR., Van DomselaarG.H, ZhangH., and WishartD.S.. 2004. SuperPose: a simple server for sophisticated structural superposition. Nucleic Acids Res. 32,(Web Server issue)::W590-4.
26.
LaskowskiR.A., MacarthurM.W, and ThorntonJ.M.. 1993. PROCHECK: a program to check the stereochemical quality of protein structures. J. Appl. Cryst. 26:283–291.
27.
MeloF., DevosD., DepiereuxE., and FeytmansE.. 1997. ANOLEA: a www server to assess protein structures. Proc. Int. Conf. on Intell. Syst. for Mol. Biol. 5:187–190.
28.
BenkertP., KünzliM., and SchwedeT.. 2009. QMEAN server for protein model quality estimation. Nucleic Acids Res. 37, (Web Server issue):W510–W514.
29.
ChristenM., HünenbergerP.H, BakowiesD., BaronR., BürgiR., GeerkeD.P, HeinzT.N, KastenholzM.A, KräutlerV., OostenbrinkC., PeterC., TrzesniakD., van GunsterenW.F. 2005. The GROMOS Software for Biomolecular Simulation: GROMOS05. J. Comput. Chem. 26:1719–1751.
30.
KabschW., and SanderC.. 1983. Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers. 22:2577–2637.
31.
SeeligerD., and de GrootB.L.. 2010. Ligand docking and binding site analysis with PyMOL and Autodock/Vina. J. Comput. Aided Mol. Des. 24:417–422.
32.
VinczeT., PosfaiJ., and RobertsR.J.. 2003. NEBcutter: a program to cleave DNA with restriction enzymes. Nucleic Acids Res. 31:3688–3691.
33.
Krumperman, P.H. 1983. Multiple antibiotic resistance indexing of Escherichia coli to identify high-risk sources of fecal contamination of foods. Appl. Environ. Microbiol. 46:165–170.
34.
XavierD.E., PicãoR.C, GirardelloR., FehlbergL.C, and GalesA.C.. 2010. Efflux pumps expression and its association with porin down-regulation and β-lactamase production among Pseudomonas aeruginosa causing bloodstream infections in Brazil. BMC Microbiol. 10:217.
35.
MuruganN., MalathiJ., UmashankarV., and MadhavanH.N.. 2014. Comparative Genomic Analysis of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates VRFPA06 and VRFPA08 with VRFPA07. Genome Announc. 2:e00140–14.
36.
Grosso-BecerraM.-V., Santos-MedellínC., González-ValdezA., MéndezJ.-L, DelgadoG., Morales-EspinosaR., Servín-GonzálezL., AlcarazL.-D, and Soberón-ChávezG.. 2014. Pseudomonas aeruginosa clinical and environmental isolates constitute a single population with high phenotypic diversity. BMC Genomics. 15:318.
37.
Soares-CastroP., MarquesD., DemyanchukS., FaustinoA., and SantosP.M.. 2011. Draft genome sequences of two Pseudomonas aeruginosa clinical isolates with different antibiotic susceptibilities. J. Bacteriol. 193:5573.
38.
van BelkumA., SoriagaL.B, LaFaveM.C, AkellaS., VeyrierasJ.-B, BarbuE.M, ShortridgeD., BlancB., HannumG., ZambardiG., MillerK., EnrightM.C, MugnierN., BramiD., SchicklinS., FeldermanM., SchwartzA.S, RichardsonT.H, PetersonT.C, HubbyB., and CadyK.C.. 2015. Phylogenetic distribution of CRISPR-Cas systems in antibiotic-resistant Pseudomonas aeruginosa. MBio. 6:e01796-15.
39.
EdalucciE., SpinelliR., DolzaniL., RiccioM.L, DuboisV., ToninE.A, RossoliniG.M, and LagatollaC.. 2008. Acquisition of different carbapenem resistance mechanisms by an epidemic clonal lineage of Pseudomonas aeruginosa. Clin. Microbiol. Infect. 14:88–90.
40.
WinsorG.L., GriffithsE.J, LoR., DhillonB.K, ShayJ.A, and BrinkmanF.S.L. 2016. Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database. Nucleic Acids Res. 44,(Database issue)::D646–D653.
41.
Ocampo-SosaA.A., CabotG., RodríguezC., RomanE., TubauF., MaciaM.D, MoyaB., ZamoranoL., SuárezC., PeñaC., DomínguezM.A, MoncaliánG., OliverA., Martínez-MartínezL., and Spanish Network for Research in Infectious Disease. 2012. Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study. Antimicrob. Agents Chemother. 56:1703–1713.
42.
ShuJ.-C., KuoA.-J, SuL.-H, LiuT.-P, LeeM.-H, SuI.-N, and WuT.-L.. 2017. Development of carbapenem resistance in Pseudomonas aeruginosa is associated with OprD polymorphisms, particularly the amino acid substitution at codon 170. J. Antimicrob. Chemother. 72:2489–2495.
43.
KöhlerT., Michea-HamzehpourM., HenzeU., GotohN., CurtyL.K, and PechereJ.C.. 1997. Characterization of MexE-MexFOprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol. Microbiol. 23:345–354.
44.
PoonsukK., TribuddharatC., and ChuanchuenR.. 2014. Simultaneous overexpression of multidrug efflux pumps in Pseudomonas aeruginosa non-cystic fibrosis clinical isolates. Can. J. Microbiol. 60:437–443.
45.
MoritaY., TomidaJ., and KawamuraY.. 2015. Efflux-mediated fluoro- quinolone resistance in the multidrug-resistant Pseudomonas aeruginosa clinical isolate PA7: identification of a novel MexS variant involved in upregulation of the mexEF-oprN multidrug efflux operon. Front. Microbiol. 6:8.
46.
WrightE.A., Di LorenzoV., TrappettiC., LiciardiM., OrruG., VitiC., BronowskiC., HallA.J, DarbyA.C, OggioniM.R, and WinstanleyC.. 2015. Divergence of a strain of Pseudomonas aeruginosa during an outbreak of ovine mastitis. Vet. Microbiol. 175:105–113.
47.
MatasejeL.F., PeiranoG., ChurchD.L, ConlyJ., MulveyM., and PitoutJ.D. 2016. Colistin-nonsusceptible Pseudomonas aeruginosa sequence type 654 with blaNDM-1 arrives in North America. Antimicrob. Agents. Chemother. 60:1794–1800.
48.
MuruganN., MalathiJ., UmashankarV., and MadhavanH.N.. 2016. Unraveling genomic and phenotypic nature of multidrug-resistant (MDR) Pseudomonas aeruginosa VRFPA04 isolated from keratitis patient. Microbiol. Res. 193:140–149.
49.
MasedaH., SaitoK., NakajimaA., and NakaeT.. 2000. Variation of the mexT gene, a regulator of the MexEF-oprN efflux pump expression in wild-type strains of Pseudomonas aeruginosa. FEMS Microbiol. Lett. 192:107–112.
50.
SinghM., YauY.C.W, WangS., WatersV., and KumarA.. 2017. MexXY efflux pump overexpression and aminoglycoside resistance in cystic fibrosis isolates of Pseudomonas aeruginosa from chronic infections. Can. J. Microbiol. 63:929–938.
51.
TriasJ., and NikaidoH.. 1990. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 34:52–57.
52.
VollanH.S., TannæsT., VriendG., and BukholmG.. 2016. In silico structure and sequence analysis of bacterial porins and specific diffusion channels for hydrophilic molecules: conservation, multimericity and multifunctionality. Int. J. Mol. Sci. 17:599.
53.
KosV.N., McLaughlinR.E, and GardnerH.A.. 2016. Identification of unique in-frame deletions in OprD among clinical isolates of Pseudomonas aeruginosa. Pathog. Dis. 74:ftw031.
54.
EppS.F., KöhlerT., PlésiatP., Michéa-HamzehpourM., FreyJ., and PechèreJ.-C.. 2001. C-terminal region of Pseudomonas aeruginosa outer membrane porin OprD modulates susceptibility to meropenem. Antimicrob. Agents Chemother. 45:1780–1787.
55.
SchiavanoG.F., CarloniE., AndreoniF., MagiS., ChironnaM., BrandiG., and AmaglianiG.. 2017. Prevalence and antibiotic resistance of Pseudomonas aeruginosa in water samples in central Italy and molecular characterization of oprD in imipenem resistant isolates. PLoS One. 12:e0189172.
56.
HammamiS., GhozziR., BurghofferB., ArletG., and RedjebS.. 2009. Mechanisms of carbapenem resistance in non-metallo-beta-lactamase-producing clinical isolates of Pseudomonas aeruginosa from a Tunisian hospital. Pathol Biol (Paris). 57:530–535.
57.
Rodríguez-MartínezJ.M., PoirelL., and NordmannP.. 2009. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob. Agents Chemother. 53:4783–4788.
58.
KaoC.-Y., ChenS.-S, HungK.-H, WuH.-M, HsuehP.-R, YanJ.-J, and WuJ.-J.. 2016. Overproduction of active efflux pump and variations of OprD dominate in imipenem-resistant Pseudomonas aeruginosa isolated from patients with bloodstream infections in Taiwan. BMC Microbiol. 16:107.
59.
PerezF.J., GimenoC., NavarroD., and Garcia-de-LomasJ.. 1996. Meropenem permeation through the outer membrane of Pseudomonas aeruginosa can involve pathways other than the OprD porin channel. Chemotherapy. 42:210–214.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
